Drug intelligence / Profile preview

PRONULIFE GasProtect

Development stage: Unknown
Lead developer: Glac Biotech
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

PRONULIFE GasProtect is a probiotic dietary supplement ingredient developed by GLAC Biotech Co., Ltd. (豐華生物科技). It is a clinically studied probiotic blend composed of three specific bacterial strains: *Lactobacillus salivarius* AP-32, *Lactobacillus rhamnosus* F-1, and *Lactobacillus plantarum* LPL28, formulated at a concentration of 100 billion CFU/g. The product is designed to support comprehensive stomach health by restoring gut microbiota balance, regulating gastric acid secretion, and promoting the repair of the gastric mucosa. Clinical studies have demonstrated its efficacy in suppressing *Helicobacter pylori* infection and reducing common gastrointestinal symptoms such as bloating, abdominal pain, and acid reflux. It is intended for oral administration as an ingredient in dietary supplements and functional foods.

Brand names: PRONULIFE GasProtect
Other names: PRONULIFE GasProtect-M

Beyond the preview

Go deeper on PRONULIFE GasProtect.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PRONULIFE GasProtect.

Explore the full profile